Treatment of patients with refractory chronic lymphocytic leukemia with alemtuzumab, alone or in combination with fludarabine
In present study the immediate and long-term therapy results of 14 patients with refractory chronic lymphocytic leukemia (CLL) are analyzed. Treatment program included alemtuzumab alone or in combination with fludarabine.
| Hlavní autoři: | , , , , , , , , , , |
|---|---|
| Médium: | Článek |
| Jazyk: | Russian |
| Vydáno: |
ABV-press
2014-07-01
|
| Edice: | Онкогематология |
| Témata: | |
| On-line přístup: | https://oncohematology.abvpress.ru/ongm/article/view/95 |